Deal Announcements

Aileron Therapeutics Raises $40 Million Series D

Wednesday, June 10, 2009 5:50:00 AM PDT | VentureDeal Staff

Cambridge, Massachusetts  --  Biotechnology company Aileron Therapeutics has garnered $40 million in its fourth round of venture capital financing.

Aileron is "applying its proprietary cell permeable type technology to generate breakthrough therapeutics for the treatment of cancer and other diseases."

SR One and GlaxoSmithKline were the lead investors in the round, which also included Excel Medical Fund, Apple Tree Partners, Novartis Venture Fund, Lilly Ventures And Roche Venture Fund.

The company said it would use the funding proceeds to advance its stapled peptide platform.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1